首页 | 本学科首页   官方微博 | 高级检索  
     


Longitudinal treatment patterns among US patients with atherosclerotic cardiovascular disease or familial hypercholesterolemia initiating lipid-lowering pharmacotherapy
Affiliation:1. Health Economics and Outcomes Research, Optum, Inc, Eden Prairie, MN, USA;2. Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA;3. Global Health Economics, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA, USA;1. Coronary Care Unit, Division of Internal Medicine, Nordland Hospital, Bodø, Norway;2. Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway;3. Dialysis Unit, Division of Internal Medicine, Nordland Hospital, Bodø, Norway;4. Research Laboratory, Nordland Hospital, Bodø, Norway;5. Institute of Clinical Medicine, Faculty of Health Sciences, K.G. Jebsen TREC, University of Tromsø, Tromsø, Norway;6. Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway;7. Department of Immunology, Oslo University Hospital Rikshospitalet, Oslo, Norway;8. K.J. Jebsen Inflammation Research Centre, University of Oslo, Oslo, Norway;1. Emory University School of Medicine, Atlanta, GA, USA;2. Heart & Lipid Institute of Florida, South Pasadena, FL, USA;3. University of Pennsylvania Health System, Philadelphia, PA, USA;4. New York University School of Medicine, New York, NY, USA;1. Department of Epidemiology, Brown University School of Public Health, Providence, RI;2. Department of Health Services, Policy and Practice, Brown University, Providence, RI;3. Optum Epidemiology, Waltham, MA;4. Department of Cardiology, Boston Children''s Hospital, and Department of Pediatrics, Harvard Medical School, Boston, MA
Abstract:
Keywords:Familial hypercholesterolemia  High-dose statin  High risk  Treatment patterns  Treatment discontinuation  Treatment switching
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号